Press Release

India Animal Pharmaceuticals Market to Grow with a CAGR of 8.25% through 2029

Growing availability of veterinary hospitals and clinics and growing occurrences of zoonotic diseases is expected to drive the India Animal Pharmaceuticals Market growth in the forecast period, 2025-2029.


According to TechSci Research report, “India Animal Pharmaceuticals Market -Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, the India Animal Pharmaceuticals Market stood at USD 427.52 Million in 2023 and is anticipated to grow with a CAGR of 8.25% in the forecast period, 2025-2029. The India Animal Pharmaceuticals Market is experiencing significant growth, driven by a range of factors. The increasing livestock population and the rising incidence of animal diseases are augmenting the demand for animal pharmaceuticals.

The growing pet adoption trend, coupled with rising awareness about pet health among urban population, is also contributing to the market expansion. Other drivers include technological advancements in animal healthcare, government initiatives towards animal health, and the increasing export of meat and dairy products.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Animal Pharmaceuticals Market.”


The Indian Animal Pharmaceuticals Market is a rapidly expanding and dynamic sector that plays a vital and indispensable role in the production, distribution, and availability of medicines specifically designed for animal health. With its continuous growth and innovation, this thriving market encompasses a wide range of pharmaceutical products, catering not only to pets and livestock but also to a diverse array of animals, ensuring their overall well-being and optimal health. The market offers an extensive selection of essential medications, including vaccines, antibiotics, antiparasitics, feed additives, and various therapeutic drugs, tailored to meet the unique healthcare needs of animals. These pharmaceutical solutions play a crucial role in safeguarding the health and welfare of animals, thereby ensuring food safety and security for the nation.

The recent surge in pet adoption and the growing emphasis on livestock health have further fueled the remarkable growth and expansion of this market in India. Moreover, the increasing awareness and recognition of zoonotic diseases, which can be transmitted between animals and humans, have highlighted the critical importance of animal healthcare and disease prevention.

By providing effective and innovative pharmaceutical solutions, the Indian Animal Pharmaceuticals Market has emerged as an integral and indispensable component of the broader animal healthcare industry. Its significant contributions not only promote the overall well-being and longevity of animals but also ensure the safety, security, and sustainability of the entire food supply chain. With its unwavering commitment to excellence and the continuous development of advanced pharmaceutical solutions, the Indian Animal Pharmaceuticals Market is poised to further revolutionize and elevate the standards of animal healthcare, ensuring a brighter and healthier future for animals and humans alike.

The Indian Animal Pharmaceuticals Market is dynamic and continuously growing, brimming with opportunities for both domestic and international players. Fuelled by a burgeoning animal husbandry sector, the demand for animal health products, including pharmaceuticals, is on the rise. India, with its vast livestock population – the largest in the world – presents an attractive market for businesses in the animal pharmaceuticals sector. In the past decade, the livestock sector's contribution to India's GDP has seen a significant increase, highlighting the sector's importance in the country's economy. As the livestock sector grows, so does the necessity for effective veterinary drugs and treatments to ensure the optimum health and productivity of animals. This trend has led to increased investment and development in the field of animal pharmaceuticals. The animal pharmaceuticals market in India is mainly segmented into poultry, dairy, and companion animals. The poultry and dairy segments hold a major market share due to the high consumption of chicken, eggs, and milk-based products. The companion animal segment, while smaller, is growing rapidly due to the rise in pet ownership and increased spending on pet healthcare.

The market is also impacted by regulatory norms and government initiatives. The Indian government, for instance, has various programs aimed at improving animal health, such as the National Programme for Bovine Breeding and Dairy Development and the Poultry Venture Capital Fund. Indian companies in the animal pharmaceuticals sector are supported by the country's strong pharmaceutical manufacturing capabilities. India is one of the largest producers of generic drugs globally, and this expertise is being leveraged to produce high-quality, affordable animal pharmaceuticals.

However, the market also faces its share of challenges. Lack of awareness about animal health and inadequate rural veterinary services are some of the obstacles to the market's growth. Further, the threat of counterfeit products and the need for stringent quality control measures are other issues that the industry grapples with.

Despite these challenges, the Indian Animal Pharmaceuticals Market offers abundant opportunities. With increasing awareness about animal health, advancements in technology, and a growing emphasis on high-quality veterinary care, the market is poised for significant growth in the coming years. International players are also showing keen interest in the Indian market. They are either entering the market through acquisitions, collaborations, or are setting up their manufacturing units in India. This trend signifies the global recognition of the market's potential. The Indian Animal Pharmaceuticals Market, backed by strong domestic demand and an increasing focus on animal health, is a key growth sector. With the right strategies and effective addressing of challenges, the market holds immense potential for all stakeholders.

The India Animal Pharmaceuticals Market is segmented into product type, product, animal type, registration, regional distribution, and company.

Based on registration, in the Indian animal pharmaceuticals market, patented drugs currently hold dominance over generic ones. This trend is primarily driven by the robust research and development efforts undertaken by pharmaceutical companies, where they invest substantial resources in developing innovative drugs and securing patent rights to protect their investments and capitalize on their innovations. However, the market dynamic is gradually shifting towards generic drugs. This shift can be attributed to several factors, including the expiration of several key patents, which paves the way for generic alternatives to enter the market. Additionally, the increasing demand for affordable and effective animal pharmaceuticals has contributed to the rising popularity of generic drugs. Their affordability makes them more accessible to a wider range of consumers, which further fuels their demand and adoption in the market. As the demand for affordable and effective animal pharmaceuticals continues to grow, the market landscape is expected to evolve further. While patented drugs still hold a dominant position, the rise of generic drugs represents a significant shift in the industry. This changing dynamic presents both challenges and opportunities for pharmaceutical companies as they navigate the delicate balance between innovation, patent protection, and market demand.

In this evolving landscape, pharmaceutical companies will need to adapt their strategies to meet the changing needs and preferences of consumers. They will need to focus not only on developing innovative drugs but also on ensuring the accessibility and affordability of their products. This could involve exploring collaborations with generic drug manufacturers or diversifying their product portfolios to include a mix of patented and generic drugs. By embracing this changing market dynamic, pharmaceutical companies can position themselves to capitalize on the growing demand for affordable animal pharmaceuticals while continuing to drive innovation in the industry.

Based on region, the northern region of India is currently leading the Indian Animal Pharmaceuticals Market due to several factors. One of the key factors is the region's robust livestock sector, which comprises a diverse range of animals including cattle, poultry, and aquaculture. This diverse livestock population creates a significant demand for veterinary pharmaceuticals to ensure the health and well-being of these animals. Furthermore, the Northern region of India boasts well-established distribution networks for pharmaceutical products, ensuring efficient and timely availability of veterinary medicines and vaccines. This accessibility is crucial in meeting the increasing demand for animal pharmaceuticals in the region. In addition, the influence of progressive farming practices in the Northern region has also contributed to its leadership position in the Animal Pharmaceuticals Market. Farmers in this region prioritize preventive healthcare for their livestock, recognizing the importance of early intervention and disease prevention. This emphasis on preventive measures has led to greater adoption of vaccines and medicines, driving the growth of the Animal Pharmaceuticals Market in Northern India. Overall, the combination of a robust livestock sector, well-established distribution networks, and progressive farming practices has propelled the Northern region of India to the forefront of the Animal Pharmaceuticals Market, making it a key player in the industry's growth and development.


Major companies operating in India Animal Pharmaceuticals Market are:

  • SeQuent Scientific Limited
  • Elanco India Private Limited
  • Merck Animal Health
  • Phibro Animal Health Limited
  • Boehringer Ingelheim Animal Health
  • Zoetis India Limited
  • Virbac Animal Health India Private Limited
  • Vetoquinol India Animal Health Private Limited
  • Perrigo Laboratories India Private Limited
  • Bayer (India) Limited


Download Free Sample Report

Customers can also request for 10% free customization on this report.


“The future of the animal pharmaceuticals market in India is expected to experience significant growth due to several key factors. The rising prevalence of animal diseases and an increasing population of livestock driven by the demand for animal-based products are expected to be major drivers. Additionally, increased awareness about animal health, coupled with the government's initiatives to promote veterinary healthcare, is further adding momentum. Technological advancements and innovation in animal healthcare, such as the development of new vaccines and medications, are also anticipated to spur the market's expansion.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

India Animal Pharmaceuticals Market By Product Type (Vaccine, Parasiticides, Anti-Infectives, Others), By Product [Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others) Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others) Anti-Inflammatories (NSAIDs, Corticosteroids, Others) Bronchodilators (Theophylline, Albuterol, Others)], By Animal Type (Companion Animals, Livestock), By Registration (Generic, Patented), By Region, Competition, Forecast & Opportunities, 2019-2019F”, has evaluated the future growth potential of India Animal Pharmaceuticals Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in India Animal Pharmaceuticals Market.



Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]


Relevant News